116 related articles for article (PubMed ID: 8495081)
1. Growth velocity and serum aminoterminal propeptide of type III procollagen in precocious puberty during gonadotropin-releasing hormone analogue treatment.
Saggese G; Bertelloni S; Baroncelli GI; Di Nero G; Battini R
Acta Paediatr; 1993 Mar; 82(3):261-6. PubMed ID: 8495081
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
[TBL] [Abstract][Full Text] [Related]
3. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis.
Saggese G; Pasquino AM; Bertelloni S; Baroncelli GI; Battini R; Pucarelli I; Segni M; Franchi G
Acta Paediatr; 1995 Mar; 84(3):299-304. PubMed ID: 7780252
[TBL] [Abstract][Full Text] [Related]
4. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
5. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
6. Changes in growth hormone-binding protein in girls with central precocious puberty treated with a depot preparation of luteinizing hormone-releasing hormone analogue.
Oliveira SB; Donnadieu M; Chaussain JL
Horm Res; 1993; 39(1-2):42-6. PubMed ID: 8406338
[TBL] [Abstract][Full Text] [Related]
7. Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion.
Saggese G; Bertelloni S; Baroncelli GI; Pardi D; Cinquanta L
J Endocrinol Invest; 1991 Mar; 14(3):231-6. PubMed ID: 1830057
[TBL] [Abstract][Full Text] [Related]
8. Effect of deslorelin dose in the treatment of central precocious puberty.
Pescovitz OH; Barnes KM; Cutler GB
J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
[TBL] [Abstract][Full Text] [Related]
9. Variations in pituitary-gonadal suppression during intranasal buserelin and intramuscular depot-triptorelin therapy for central precocious puberty. Belgian Study Group for Pediatric Endocrinology.
Heinrichs C; Craen M; Vanderschueren-Lodeweyckx M; Malvaux P; Fawe L; Bourguignon JP
Acta Paediatr; 1994 Jun; 83(6):627-33. PubMed ID: 7919761
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
[TBL] [Abstract][Full Text] [Related]
11. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH)].
Couprie C; Roger M; Chaussain JL
J Steroid Biochem; 1989 Oct; 33(4B):805-8. PubMed ID: 2532270
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
[TBL] [Abstract][Full Text] [Related]
14. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of precocious puberty with LH-RH agonists. Multicenter study using D-Trp-6-LH-RH in a programmed-release form].
Roger M; Chaussain JL; Bost M; Bozzola M; Colle M; Despert F; François R; Freycon F; Garandeau P; Malpuech G
Rev Fr Gynecol Obstet; 1986 May; 81(5):297-305. PubMed ID: 2943013
[TBL] [Abstract][Full Text] [Related]
16. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of triptorelin 6-month formulation in patients with central precocious puberty.
Klein K; Yang J; Aisenberg J; Wright N; Kaplowitz P; Lahlou N; Linares J; Lundström E; Purcea D; Cassorla F
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1241-1248. PubMed ID: 26887034
[TBL] [Abstract][Full Text] [Related]
18. [Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth].
Hofmann-Ehrhart B; Schulz U; Kluge M; Wandl-Vergesslich K; Waldhauser F
Wien Klin Wochenschr; 1995; 107(14):413-7. PubMed ID: 7668000
[TBL] [Abstract][Full Text] [Related]
19. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
[TBL] [Abstract][Full Text] [Related]
20. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
